Denise Drago

Denise Drago

Auto-generated profile, based on publicly available information

Denise Drago

Proteomics and Metabolomics Facility (ProMeFa), IRCCS San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, MI, Italy

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2009 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
PZPaolo Zatta
Paolo Zatta
DDDenise Drago
Denise Drago
SBSilvia Bolognin
Silvia Bolognin
SSStefano L. Sensi
Stefano L. Sensi

1 December 2013 in Biochimie
Verified
Journal Article
Open access
DDDenise Drago
Denise Drago
CCChiara Cossetti
Chiara Cossetti
Nunzio IraciNunzio Iraci
Nunzio Iraci
EGEdoardo Gaude
Edoardo Gaude
GMGiovanna Musco
Giovanna Musco
Stefano PluchinoStefano Pluchino
Stefano Pluchino
Compelling evidence exists that non-haematopoietic stem cells, including mesenchymal (MSCs) and neural/progenitor stem cells (NPCs), exert a substantial beneficial and therapeutic effect after transplantation in experimental central nervous system (CNS) disease models through the secretion of immune modulatory or neurotrophic paracrine factors. This paracrine hypothesis has inspired an alternative outlook on the use of stem cells in regenerative neurology. In this paradigm, significant repair of the injured brain may be achieved by injecting the biologics secreted by stem cells (secretome), rather than implanting stem cells themselves for direct cell replacement. The stem cell secretome (SCS) includes cytokines, chemokines and growth factors, and has gained increasing attention in recent years because of its multiple implications for the repair, restoration or regeneration of injured tissues. Thanks to recent improvements in SCS profiling and manipulation, investigators are now inspired to harness the SCS as a novel alternative therapeutic option that might ensure more efficient outcomes than current stem cell-based therapies for CNS repair. This review discusses the most recent identification of MSC- and NPC-secreted factors, including those that are trafficked within extracellular membrane vesicles (EVs), and reflects on their potential effects on brain repair. It also examines some of the most convincing advances in molecular profiling that have enabled mapping of the SCS.

1 October 2014 in Molecular Cell
Verified
Journal Article
Closed access
CCChiara Cossetti
Chiara Cossetti
Nunzio IraciNunzio Iraci
Nunzio Iraci
TMTim R. Mercer
Tim R. Mercer
TLTommaso Leonardi
Tommaso Leonardi
EAEmanuele Alpi
Emanuele Alpi
Stefano PluchinoStefano Pluchino
Stefano Pluchino

1 June 2011 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
SBSilvia Bolognin
Silvia Bolognin
Luigi MessoriLuigi Messori
Luigi Messori
DDDenise Drago
Denise Drago
Chiara GabbianiChiara Gabbiani
Chiara Gabbiani
LCLaura Cendron
Laura Cendron
PZPaolo Zatta
Paolo Zatta

30 June 2005 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
FRF. Ricchelli
F. Ricchelli
DDD. Drago
D. Drago
BFB. Filippi
B. Filippi
GTG. Tognon
G. Tognon
PZP. Zatta
P. Zatta

1 December 2008 in Current Alzheimer Research
Verified
Journal Article
Closed access
DDD. Drago
D. Drago
SBS. Bolognin
S. Bolognin
PZP. Zatta
P. Zatta
Neurodegeneration is a complex and multifaceted process leading to many chronic diseased states. Neurodegenerative disorders include a number of different pathological conditions, like Alzheimers and Parkinsons diseases, which share similar critical metabolic processes, such as protein aggregation, which could be affected by some metal ions. A huge number of reports indicate that, among putative aggravating factors, metal ions (Al, Zn, Cu, Fe) could specifically impair protein aggregation of Aβ, prion protein, ataxin, huntingtin, etc. and their oligomeric toxicity. While studying the molecular basis of these diseases, it has become clear that protein conformation plays a critical role in the pathogenic process. In this review, we will focus on Alzheimers disease and on the role of metal ions, specifically aluminium, in affecting amyloid aggregation, oligomerization and toxicity.